Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects

[cafead]

via Novartis has scrapped work on its Rett syndrome gene therapy AVXS-201 after finding the data don’t support further development. The action follows Novartis’ decision to gather extra data on the candidate in response to data manipulation during development of Zolgensma.

article source